The 8 highest-scored Clinical-stage Biopharmaceuticals companies in the AskCyborg corpus, ranked by Cyborg Score — a 1–10 rating from a bull-vs-bear AI analyst debate across 11 dimensions. Leading the table: AtaiBeckley Inc. (7/10), NervGen Pharma Corp (7/10), Trevi Therapeutics, Inc. (7/10).
| # | Company | Cyborg Score | The verdict | Ownership | Peers |
|---|---|---|---|---|---|
| 1 | AtaiBeckley Inc. | 7/10 | Diversified psychedelic pipeline with strong BPL-003 clinical data and potential 20% market share in TRD treatment offers compelling upside | Public | |
| 2 | NervGen Pharma Corp | 7/10 | Clinical-stage biotech with potentially first pharmacological therapy for spinal cord injury and clear regulatory pathway. | Public | |
| 3 | Trevi Therapeutics, Inc. | 7/10 | Clinical-stage biotech with potentially differentiated therapy for chronic cough in IPF; success depends on Phase 3 outcomes and regulatory | Public | |
| 4 | Disc Medicine, Inc. | 6/10 | Clinical-stage hematology biotech with differentiated targets and strong balance sheet, but near-term catalysts clouded by FDA bitopertin de | Public | |
| 5 | Sagimet Biosciences Inc. | 6/10 | Early-stage biotech with promising FASN inhibitor portfolio targeting high-unmet-need metabolic diseases; Phase III progress could drive sig | Public | |
| 6 | OnKure Therapeutics, Inc. | 4/10 | Following transactions, OnKure is expected to have a cash runway through multiple clinical readouts and into Q4-2026. | Public | |
| 7 | Pliant Therapeutics, Inc. | 4/10 | Turnaround opportunity dependent on oncology program success, but faces execution risk and cash runway constraints. | Public | |
| 8 | Applied Therapeutics, Inc. | 3/10 | Distressed biotech acquisition reflecting clinical setbacks and cash burn that forced near-term strategic sale. | Private |
See also Clinical-stage Biopharmaceuticals industry research and the full industry ratings index.
Cyborg Scores (1–10) are synthesized by AskCyborg’s multi-agent analyst-debate framework across 11 dimensions, recalibrated weekly. How the score works · Methodology.